Literature DB >> 20960166

Preliminary biochemical characterization of the novel, non-AT1, non-AT2 angiotensin binding site from the rat brain.

Vardan T Karamyan1, Jason Arsenault, Emanuel Escher, Robert C Speth.   

Abstract

A novel binding site for angiotensins II and III was recently discovered in brain membranes in the presence of the sulfhydryl reactive angiotensinase inhibitor parachloromercuribenzoate. This binding site is distinctly different from the other known receptors for angiotensins: AT₁, AT₂, AT₄, and mas oncogene protein (Ang 1-7 receptor). Preliminary biochemical characterization studies have been done on this protein by crosslinking it with (125)I-labeled photoaffinity probes and solubilizing the radiolabeled binding site. Polyacrylamide gel electrophoresis studies and isoelectric focusing indicate that this membrane bound binding site is a protein with a molecular weight of 70-85 kDa and an isoelectric point of ~7. Cyanogen bromide hydrolysis of the protein yielded two radiolabeled fragments of 12.5 and 25 kDa. The protein does not appear to be N-glycosylated based upon the failure of PNGaseF to alter its migration rate on a 7.5% polyacrylamide gel. The binding of angiotensin II to this protein is not affected by GTPγS or Gpp(NH)p, suggesting that it is not a G protein-coupled receptor. Further characterization studies are directed to identify this protein either as a novel angiotensin receptor, an angiotensin scavenger (clearance receptor) or an angiotensinase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960166      PMCID: PMC3176303          DOI: 10.1007/s12020-010-9328-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  48 in total

1.  The AT2 subtype of the angiotensin II receptors has differential sensitivity to dithiothreitol in specific brain nuclei of young rats.

Authors:  K Tsutsumi; S Zorad; J M Saavedra
Journal:  Eur J Pharmacol       Date:  1992-06-05       Impact factor: 4.432

2.  Temperature-dependent variations of ligand-receptor contact points in hAT(1).

Authors:  J Arsenault; M P La Haye Renaud; M Clément; D Fillion; G Guillemette; R Leduc; P Lavigne; E Escher
Journal:  J Pept Sci       Date:  2007-09       Impact factor: 1.905

3.  Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.

Authors:  R C Speth; K H Kim
Journal:  Biochem Biophys Res Commun       Date:  1990-06-29       Impact factor: 3.575

4.  Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.

Authors:  A Arregui; P C Emson; E G Spokes
Journal:  Eur J Pharmacol       Date:  1978-11-01       Impact factor: 4.432

5.  Biochemical characterization of two distinct angiotensin AT2 receptor populations in murine neuroblastoma N1E-115 cells.

Authors:  I R Siemens; L P Reagan; D K Yee; S J Fluharty
Journal:  J Neurochem       Date:  1994-06       Impact factor: 5.372

Review 6.  Alzheimer's, angiotensin IV and an aminopeptidase.

Authors:  Anthony Lloyd Albiston; Ruani Fernando; Siying Ye; Grantley Ross Peck; Siew Yeen Chai
Journal:  Biol Pharm Bull       Date:  2004-06       Impact factor: 2.233

7.  Localization of preangiotensinogen messenger RNA sequences in the rat brain.

Authors:  K R Lynch; V I Simnad; E T Ben-Ari; J C Garrison
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

8.  Distribution of a novel binding site for angiotensins II and III in mouse tissues.

Authors:  Felicia M Rabey; Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2010-02-19

Review 9.  Brain renin angiotensin in disease.

Authors:  M Ian Phillips; Edilamar Menezes de Oliveira
Journal:  J Mol Med (Berl)       Date:  2008-04-02       Impact factor: 4.599

Review 10.  Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges.

Authors:  Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2007-03-30
View more
  5 in total

1.  Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.

Authors:  Srinidhi Jayaraman; Abdullah Al Shoyaib; Joanna Kocot; Heidi Villalba; Faisal F Alamri; Mamoon Rashid; Naomi J Wangler; Ekram A Chowdhury; Nadezhda German; Thiruma V Arumugam; Thomas J Abbruscato; Vardan T Karamyan
Journal:  J Neurochem       Date:  2019-10-22       Impact factor: 5.372

2.  Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site.

Authors:  Naomi J Wangler; Kira L Santos; Ines Schadock; Fred K Hagen; Emanuel Escher; Michael Bader; Robert C Speth; Vardan T Karamyan
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

3.  Pharmacological characterization of a novel non-AT1, non-AT2 angiotensin binding site identified as neurolysin.

Authors:  Jamala D Swindle; Kira L Santos; Robert C Speth
Journal:  Endocrine       Date:  2013-02-15       Impact factor: 3.633

4.  AT₁ angiotensin II receptor and novel non-AT₁, non-AT₂ angiotensin II/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat.

Authors:  Erick A Bourassa; Xiefan Fang; Xia Li; Alan F Sved; Robert C Speth
Journal:  Brain Res       Date:  2010-08-31       Impact factor: 3.252

Review 5.  LOX-1 and angiotensin receptors, and their interplay.

Authors:  Xianwei Wang; M Ian Phillips; Jawahar L Mehta
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.